Issued Patents All Time
Showing 26–50 of 198 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11253572 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2022-02-22 |
| 11051499 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2021-07-06 |
| 11026408 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Markus Manz, Anthony Rongvaux, Till Strowig, Tim Willinger +2 more | 2021-06-08 |
| 10988776 | Methods of modifying genes in eukaryotic cells | Aris N. Economides, David M. Valenzuela, Samuel Davis | 2021-04-27 |
| 10975390 | Targeted modification of rat genome | Jeffrey D. Lee, Alexander O. Mujica, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2021-04-13 |
| 10975139 | Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2021-04-13 |
| 10954289 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2021-03-23 |
| 10935554 | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT) | Jamie M. Orengo | 2021-03-02 |
| 10888601 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2021-01-12 |
| 10857205 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2020-12-08 |
| 10828345 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2020-11-10 |
| 10815305 | Methods of treating inflammatory conditions | Jamie M. Orengo, Jeanne Allinne, Andrew J. Murphy | 2020-10-27 |
| 10785968 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Till Strowig, Markus Manz, Chiara Borsotti, Madhav Dhodapkar +2 more | 2020-09-29 |
| 10785966 | Humanized M-CSF mice | Andrew J. Murphy, Sean Stevens, Chozhavendan Rathinam, Elizabeth Eynon, Markus Manz +1 more | 2020-09-29 |
| 10787501 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2020-09-29 |
| 10711280 | Methods and compositions for the targeted modification of a mouse ES cell genome | David Frendewey, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2020-07-14 |
| 10640800 | Mice that produce hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2020-05-05 |
| 10626168 | B cell lineage based immunogen design with humanized animals | Barton F. Haynes, Garnett Kelsoe, Israel Lowy, Aris Baras, Lynn Macdonald +4 more | 2020-04-21 |
| 10598669 | Isolating cells expressing secreted proteins | James P. Fandl, Gang Chen, Neil Stahl | 2020-03-24 |
| 10584364 | Mice that produce hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2020-03-10 |
| 10561126 | Genetically modified non-human animals and methods of use thereof | Dietmar Herndler-Brandstetter, Richard Flavell, Davor Frleta, Cagan Gurer, Markus Manz +6 more | 2020-02-18 |
| 10526630 | Genetically modified mice that produce hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2020-01-07 |
| 10526403 | Anti-activin A antibodies and uses thereof | Jesper Gromada, Esther Latres, Andrew J. Murphy, Lori C. Morton | 2020-01-07 |
| 10519240 | Anti-FGFR1c antibody-FGF21 fusion proteins | Andrew J. Murphy, Jesper Gromada, David Buckler, Kihwa Kang | 2019-12-31 |
| 10457960 | Methods and compositions for targeted genetic modification using paired guide RNAs | David Frendewey, Ka-Man Venus Lai, Wojtek Auerbach, Gustavo Droguett, Anthony Gagliardi +4 more | 2019-10-29 |